An analysis of the biomolecule substudy of the EAST–AFNET 4 trial has revealed that biomolecule concentrations in the blood of patients with atrial fibrillation can be used to identify patients at high and low cardiovascular ...
Apr 15, 2024
0
0
Treatment with ticagrelor alone results in a lower rate of clinically relevant bleeding compared with ticagrelor and aspirin among patients with an acute coronary syndrome who had percutaneous coronary intervention and remained ...
Apr 13, 2024
0
10
People taking medical cannabis for chronic pain have a slightly increased risk of arrhythmia, according to research published in the European Heart Journal today (Thursday). Arrhythmia is when the heart beats too slowly, ...
Jan 10, 2024
0
18
Researchers have studied the association of proprotein convertase subtilisin/kexin type 9 (PCSK9) with soluble P-selectin (sP-selectin) and their values in predicting major adverse cardiovascular events (MACE) at one-year ...
Jan 8, 2024
0
0
In a guideline update issued by the Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology and published online Oct. 28 in the Canadian Journal of Cardiology, new recommendations are presented regarding ...
Dec 23, 2023
0
0
A new review article, published in Cardiovascular Innovations and Applications offers solutions to improve access to underutilized cardiac rehabilitation.
Nov 24, 2023
0
0
Young patients from the Middle East and Gulf region presenting with acute coronary syndrome have a greater prevalence of risk factors, including smoking and high cholesterol compared to older patients also presenting with ...
Nov 1, 2023
0
0
For patients with acute coronary syndrome (ACS), stopping dual antiplatelet therapy (DAPT) within one month for ticagrelor monotherapy is noninferior and superior to 12 months of ticagrelor-based DAPT, according to a study ...
Oct 27, 2023
0
0
The health care landscape has undergone rapid changes in recent years, requiring clinicians and stakeholders to consider innovative ways to provide care in traditional and non-traditional settings. The American College of ...
Sep 26, 2023
0
1
Patients who have suffered a heart attack should immediately be offered a combination of cholesterol lowering drugs with statins and ezetimibe, according to research published in the Journal of the American Heart Association.
Sep 6, 2023
0
8
